Hypolipidemic effects of herbal extracts by reduction of adipocyte differentiation, intracellular neutral lipid content, lipolysis, fatty acid exchange and lipid droplet motility.
Adipocytes
/ chemistry
Berberine
/ pharmacology
Berberis
/ chemistry
Cell Differentiation
/ drug effects
Cell Line
Chelidonium
/ chemistry
Chromatography, Gas
Chromatography, High Pressure Liquid
Coptis
/ chemistry
Fatty Acids
/ metabolism
Gas Chromatography-Mass Spectrometry
Humans
Hypolipidemic Agents
/ pharmacology
Lipid Droplets
/ drug effects
Lipids
/ analysis
Lipolysis
/ drug effects
Mahonia
/ chemistry
Plant Extracts
/ pharmacology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 07 2019
19 07 2019
Historique:
received:
23
08
2018
accepted:
05
07
2019
entrez:
21
7
2019
pubmed:
22
7
2019
medline:
21
10
2020
Statut:
epublish
Résumé
An increase in adipose tissue is caused by the increased size and number of adipocytes. Lipids accumulate in intracellular stores, known as lipid droplets (LDs). Recent studies suggest that parameters such as LD size, shape and dynamics are closely related to the development of obesity. Berberine (BBR), a natural plant alkaloid, has been demonstrated to possess anti-obesity effects. However, it remains unknown which cellular processes are affected by this compound or how effective herbal extracts containing BBR and other alkaloids actually are. For this study, we used extracts of Coptis chinensis, Mahonia aquifolium, Berberis vulgaris and Chelidonium majus containing BBR and other alkaloids and studied various processes related to adipocyte functionality. The presence of extracts resulted in reduced adipocyte differentiation, as well as neutral lipid content and rate of lipolysis. We observed that the intracellular fatty acid exchange was reduced in different LD size fractions upon treatment with BBR and Coptis chinensis. In addition, LD motility was decreased upon incubation with BBR, Coptis chinensis and Chelidonium majus extracts. Furthermore, Chelidonium majus was identified as a potent fatty acid uptake inhibitor. This is the first study that demonstrates the selected regulatory effects of herbal extracts on adipocyte function.
Identifiants
pubmed: 31324860
doi: 10.1038/s41598-019-47060-4
pii: 10.1038/s41598-019-47060-4
pmc: PMC6642187
doi:
Substances chimiques
Fatty Acids
0
Hypolipidemic Agents
0
Lipids
0
Plant Extracts
0
Berberine
0I8Y3P32UF
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10492Références
Physiol Behav. 2008 May 23;94(2):219-30
pubmed: 18262211
Biochem Biophys Res Commun. 2011 Sep 23;413(2):376-82
pubmed: 21893041
Atherosclerosis. 2008 Dec;201(2):266-73
pubmed: 18355829
Biophys J. 2004 Nov;87(5):3518-24
pubmed: 15339818
Exp Mol Med. 2006 Dec 31;38(6):599-605
pubmed: 17202835
Nat Rev Mol Cell Biol. 2013 Dec;14(12):775-86
pubmed: 24220094
PLoS One. 2017 Aug 4;12(8):e0182788
pubmed: 28777818
FEBS J. 2015 Mar;282(6):987-1005
pubmed: 25627174
Int J Mol Sci. 2016 Nov 09;17(11):
pubmed: 27834848
Trends Cell Biol. 2016 Jul;26(7):535-546
pubmed: 26995697
Pharm Biol. 2016 Dec;54(12):3264-3271
pubmed: 27569515
Nat Med. 2004 Dec;10(12):1344-51
pubmed: 15531889
Biochem Soc Trans. 2009 Oct;37(Pt 5):991-6
pubmed: 19754438
J Lipid Res. 2014 Jan;55(1):94-103
pubmed: 24179149
Cell Tissue Res. 1998 Nov;294(2):309-21
pubmed: 9799447
FEBS Lett. 2010 Jun 3;584(11):2176-82
pubmed: 20303960
Phytomedicine. 2014 Apr 15;21(5):758-65
pubmed: 24369814
Molecules. 2016 Sep 23;21(10):
pubmed: 27669202
Sci China Life Sci. 2017 Jan;60(1):46-56
pubmed: 27981432
Fitoterapia. 2010 Jul;81(5):358-66
pubmed: 19861153
Traffic. 2008 Mar;9(3):338-52
pubmed: 18088320
Methods. 2006 Jun;39(2):147-53
pubmed: 16846741
Biochem Biophys Res Commun. 2012 Apr 20;420(4):805-10
pubmed: 22465130
J Biol Chem. 2009 Nov 6;284(45):30941-8
pubmed: 19748893
Diabetologia. 2012 Oct;55(10):2551-2554
pubmed: 22660796
Diabetes. 2004 Jun;53(6):1412-7
pubmed: 15161742
Mol Nutr Food Res. 2018 Jun;62(11):e1701012
pubmed: 29688623
J Lipid Res. 2006 Jun;47(6):1281-8
pubmed: 16508037
Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E706-13
pubmed: 20028967
Obes Res. 2004 May;12(5):761-9
pubmed: 15166296
J Pharm Anal. 2017 Apr;7(2):77-86
pubmed: 29404021
Int J Obes (Lond). 2010 Feb;34(2):250-60
pubmed: 19859078
Mol Med Rep. 2017 Jun;15(6):4139-4147
pubmed: 28487951
Methods. 2008 Oct;46(2):131-40
pubmed: 18634880
J Sep Sci. 2010 Apr;33(8):1004-9
pubmed: 20183823
Diabetes. 2004 Feb;53 Suppl 1:S119-24
pubmed: 14749276
Phytother Res. 2010 Dec;24(12):1831-8
pubmed: 20564506
Br J Pharmacol. 2014 Dec;171(23):5237-51
pubmed: 25039620
Phys Rev Lett. 2011 Jan 28;106(4):048103
pubmed: 21405366
Pharmacogn Mag. 2017 Jan-Mar;13(49):175-179
pubmed: 28216903
Mol Metab. 2015 Dec 31;5(3):153-163
pubmed: 26977387
FEMS Microbiol Lett. 1998 Mar 1;160(1):87-90
pubmed: 9495017
BMB Rep. 2012 Dec;45(12):700-6
pubmed: 23261055
Biochim Biophys Acta. 2010 Feb;1801(2):198-204
pubmed: 19932762
Phytother Res. 2003 Aug;17(7):834-7
pubmed: 12916091
Trends Mol Med. 2002 Sep;8(9):442-7
pubmed: 12223316
Bioorg Med Chem. 2015 Aug 1;23(15):4719-4727
pubmed: 26088335
Toxicol Appl Pharmacol. 2017 Feb 1;316:74-82
pubmed: 28038998
Biochem Biophys Res Commun. 2011 Sep 23;413(2):259-63
pubmed: 21884681
Biochem Biophys Res Commun. 2007 Sep 7;360(4):797-801
pubmed: 17631276
PLoS One. 2015 Apr 30;10(4):e0125667
pubmed: 25928058
PLoS One. 2016 Jan 28;11(1):e0148109
pubmed: 26820984
Biosci Biotechnol Biochem. 2013;77(12):2405-12
pubmed: 24317056
Biochim Biophys Acta. 2011 Apr;1812(4):527-35
pubmed: 20969954
Metabolism. 2008 May;57(5):712-7
pubmed: 18442638
J Biol Chem. 2003 May 2;278(18):15998-6007
pubmed: 12591929
Science. 2001 Nov 30;294(5548):1929-32
pubmed: 11729319
Biophys J. 2008 Nov 15;95(10):4908-14
pubmed: 18689461
J Cell Sci. 2014 Jul 15;127(Pt 14):3104-15
pubmed: 24876224
Nutr Metab (Lond). 2009 May 01;6:20
pubmed: 19409077
FASEB J. 2001 Feb;15(2):312-21
pubmed: 11156947
Phys Biol. 2013 Jun;10(3):036002
pubmed: 23574726
Cold Spring Harb Perspect Biol. 2011 Mar 01;3(3):
pubmed: 21421923
Biofactors. 2010 Nov-Dec;36(6):415-22
pubmed: 20803522
Nature. 2006 Dec 14;444(7121):847-53
pubmed: 17167472
Phys Rev Lett. 2009 Jul 3;103(1):018102
pubmed: 19659180
J Am Soc Mass Spectrom. 2003 Nov;14(11):1262-9
pubmed: 14597116
Cell. 2008 Oct 17;135(2):240-9
pubmed: 18835024
J Lipid Res. 1997 Nov;38(11):2249-63
pubmed: 9392423
Fitoterapia. 2014 Oct;98:199-208
pubmed: 25128422
FEBS Lett. 2011 Jun 23;585(12):1946-50
pubmed: 21575639
Chin Med. 2009 Aug 24;4:17
pubmed: 19703289
J Lipid Res. 2008 Jan;49(1):230-44
pubmed: 17928635
Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E486-96
pubmed: 20570821
Biochem Biophys Res Commun. 2006 Sep 22;348(2):571-8
pubmed: 16890192
Adipocyte. 2015 Apr 18;4(4):295-302
pubmed: 26451286
Diabetes Metab J. 2012 Feb;36(1):13-25
pubmed: 22363917
Diabetes. 2006 Aug;55(8):2256-64
pubmed: 16873688
J Nat Med. 2014 Apr;68(2):253-66
pubmed: 24550097